Search results
Results from the WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
Hence, a detailed knowledge of the treatment history of each patient is essential. In addition to the obvious risks (i.e., known exposure to a patient with MDR-TB), risk factors for MDR-TB include HIV infection, previous incarceration, failed TB treatment, failure to respond to standard TB treatment, and relapse following standard TB treatment.
In 2018, one quarter of the world's population was thought to have a latent infection of TB. [6] New infections occur in about 1% of the population each year. [11] In 2022, an estimated 10.6 million people developed active TB, resulting in 1.3 million deaths, making it the second leading cause of death from an infectious disease after COVID-19. [1]
While benefits include being able to take less pills, it is unclear if this version changes peoples adherence to treatment. [2] Other studies, however, have found fixed-dose combinations to be useful for this purpose.
In vitro and in vivo activity against both nonresistant and MDR strains of TB. [51] [52] [53] Whipple's disease: No: No: No: Co-trimoxazole is the recommended standard treatment for whipple's disease in some treatment protocols. [54] [55] [56] Fungal and protozoal infections: Isosporiasis: No: No: No: Clinical trials have confirmed its use in ...
Isoniazid can be used alone or in combination with Rifampin for treatment of latent tuberculosis, or as part of a four-drug regimen for treatment of active tuberculosis. [27] The drug regimen typically requires daily or weekly oral administration for a period of three to nine months, often under Directly Observed Therapy (DOT) supervision. [27]
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.
Tuberculosis: Used in combination with other antibiotics. For active tuberculosis it is often given together with isoniazid, rifampicin, and pyrazinamide. [4] It is not the first-line treatment, except in medically under-served populations where the cost of more expensive treatments is prohibitive.